20:48 , Oct 23, 2018 |  BC Extra  |  Company News

Management tracks: Celgene, Seres, AC Immune

Celgene Corp. (NASDAQ:CELG) hired Alise Reicin as president of global clinical development, a newly created position. She was SVP and head of global clinical development in R&D at the EMD Serono business of Merck KGaA...
16:33 , Sep 21, 2018 |  BC Week In Review  |  Financial News

Biodesy raises $20M in series C, appoints new CEO

Biodesy Inc. (South San Francisco, Calif.) raised $20 million Sept. 10 in a series C round led by new investor Alexandria Venture Investments. Existing investors 5AM Ventures, Pfizer Ventures and Roche Venture Fund also participated...
23:21 , Sep 10, 2018 |  BC Extra  |  Company News

Management tracks: PolarityTE, Medivir

Regenerative biomaterial company PolarityTE Inc. (NASDAQ:COOL) terminated Chief Investment Officer and EVP John Stetson on Friday after the Securities and Exchanges Commission filed charges against him alleging his involvement in "pump-and-dump" schemes (see "Opko's Frost...
23:47 , Jul 5, 2017 |  BC Extra  |  Company News

Management tracks

Regenacy Pharmaceuticals LLC (Boston, Mass.) named Simon Jones president and CEO. He was VP of biology at EPIX Pharmaceuticals Inc. (Pink:EPIX). Jones succeeds Walter Ogier, who will remain a director. Last December, Acetylon Pharmaceuticals Inc....
08:00 , Jan 25, 2016 |  BC Week In Review  |  Financial News

Biodesy completes venture financing

Biodesy Inc. , Burlingame, Calif.   Business: Supply/Service, Computational chemistry/biology, Proteomics   Date completed: 2016-01-21   Type: Venture financing   Raised: $10 million   Investors: 5AM Ventures; Pfizer Venture Investments; Roche Venture Fund  ...
07:00 , Oct 21, 2013 |  BC Week In Review  |  Company News

Biodesy board of directors update

Biodesy Inc. , Burlingame, Calif.   Business: Proteomics, Supply/Service, Computational chemistry/biology   Appointed: William Burkoth, senior director of Pfizer Ventures; and Andrew Schwab, managing partner of 5AM Ventures  ...
07:00 , Oct 21, 2013 |  BC Week In Review  |  Financial News

Biodesy completes venture financing

Biodesy Inc. , Burlingame, Calif.   Business: Supply/Service, Computational chemistry/biology, Proteomics   Date completed: 10/17/13   Type: Venture financing   Raised: $15 million   Investors: 5AM Ventures; Pfizer Venture Investments; Roche Venture Fund  ...
07:00 , Oct 21, 2013 |  BC Week In Review  |  Company News

Biodesy management update

Biodesy Inc. , Burlingame, Calif.   Business: Proteomics, Supply/Service, Computational chemistry/biology   Hired: Greg Yap as CEO and a director, formerly healthcare entrepreneur-in-residence at General Electric Co.  ...
07:00 , Oct 21, 2013 |  BioCentury  |  Finance

Cashing in on Conformations

Cashing in on Conformations Biodesy Inc. has yet to commercialize its system for protein structure analysis, but a trio of investors are betting the platform's low cost and simplicity will eventually allow for scalability and...
00:23 , Oct 18, 2013 |  BC Extra  |  Financial News

Biodesy raises $15 million in series A, names CEO

Biodesy Inc. (Burlingame, Calif.) raised $15 million in a series A round led by new investor 5AM Ventures. New investors Pfizer Venture Investments and Roche Venture Fund also participated. Additionally, Biodesy named Greg Yap as...